Physician profile
Khurram Arshad
NPI 1720717234
$1,082.95
in general payments reported to CMS, 2019-2025
13 companies · $836 in 2025
The $836 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $92.68 · 2024: $154 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.57 |
| Education | $164.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $176.38 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $142.91 | 2025 | Indigo System |
| Abiomed | $133.12 | 2025 | |
| Stryker Corporation | $106.96 | 2025 | Clottriever Bold Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.21 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $92.68 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $77.74 | 2025 | |
| Chiesi USA, INC. | $75.13 | 2025 | Kengreal |
| Kestra Medical Technology Services, INC. | $60.71 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $39.03 | 2025 | Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $31.21 | 2025 | Avvigo Guidance System |
| Bridgebio Pharma, INC. | $25.52 | 2025 | Attruby |
| Teleflex LLC | $18.35 | 2025 | Trapliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khurram Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.